GF
ABBV icon

GGM Financials’s AbbVie ABBV Stock Holding History

GGM Financials’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Sell
5,528
-288
-5% -$62K 0.53% 27
2026
Q1 		$1.26M Sell
5,816
-575
-9% -$128K 0.58% 25
2025
Q4 		$1.46M Buy
6,391
+39
+0.6% +$8.88K 0.71% 22
2025
Q3 		$1.47M Buy
6,352
+6
+0.1% +$1.22K 0.74% 21
2025
Q2 		$1.18M Sell
6,346
-627
-9% -$117K 0.68% 23
2025
Q1 		$1.46M Buy
6,973
+21
+0.3% +$4.08K 1% 14
2024
Q4 		$1.24M Buy
6,952
+57
+0.8% +$10.5K 1.32% 15
2024
Q3 		$1.36M Buy
6,895
+50
+0.7% +$9.33K 1.17% 13
2024
Q2 		$1.17M Buy
+6,845
New +$1.13M 1.08% 17

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GGM Financials's ABBV Position: Q2 2026 in Review

GGM Financials reduced its AbbVie (ABBV) stake by 5% in Q2 2026, selling an estimated $62K and leaving 5,528 shares worth $1.39M. The position accounts for 0.53% of the portfolio, ranked #27.

GGM Financials first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.47M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • GGM Financials held 5,528 shares of AbbVie worth $1.39M as of Q2 2026.
  • GGM Financials sold 288 AbbVie shares in Q2 2026, an estimated $62K.
  • AbbVie made up 0.53% of GGM Financials's portfolio in Q2 2026, its #27 holding.
  • GGM Financials first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • GGM Financials's AbbVie position peaked at $1.47M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GGM Financials's 13F filing for Q2 2026, filed 23 Jul 2026.